Live Quote · NASDAQTRDAHealthcare· Biotechnology

Entrada Therapeutics, Inc.

$4.35▼ 6.25%($-0.29)
MKT CAP $170.30MNEXT EARNINGS Feb 25, 2027
50%
Bullish
TickerSpark Score
48/100
▌ Weak
75
Valuation
40
Profitability
10
Growth
84
Health
30
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a TRDA research report →

Analyst Price Target
$14.00+221.8% vs. today

Range $11 – $17

Analyst RatingBuy
4 Buy2 Hold0 Sell

Price Chart

-52.56% · this period
$16.03$10.19$4.35Nov 20May 26Nov 20
52-Week Range2% of range
Low
$4.11
Current
$4.35
High
$16.45